Israeli startup Nucleai is developing computer vision and artificial intelligence (AI) to help overworked pathologists process and analyze biopsies for cancer quicker and more accurately. Nucleai founders have years of experience of computer vision gained during their IDF service.
Using AI to analyze biopsies
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.